MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, RGBPP made $59,065 in revenue. $991,927 in net income. Net profit margin of 1679.38%.

Income Overview

Revenue
$59,065
Net Income
$991,927
Net Profit Margin
1679.38%
Unit: Dollar
Revenue Breakdown
    • Nonrelated Party
    • Related Party

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net revenue
59,065 59,065 59,366* 59,065
Research and development
2,216 210,000 11,725* 0
General and administrative
32,104 231,925 -16,978* 30,697
Consulting and professional fees
178,454 153,764 258,391* 46,624
Rent
0 15,000 22,500* 22,500
Total operating expenses
212,774 610,689 275,638* 99,821
Profit (loss) from operations
-153,709 -551,624 -216,272* -40,756
Interest expense
27,388 26,553 84,372* 24,638
Interest expense attributable to amortization of discount
8,656 8,850 14,231* 12,639
Derivative income (expense)
1,181,680 -380,826 -445,251* -89,259
Penalties
0 0 12,500* -
Financing fees
0 0 --
Total other income (expense), net
1,145,636 -416,229 -556,354* -126,536
Net profit (loss) before income taxes
991,927 -967,853 -772,626* -167,292
Income tax provision
0 0 0* 0
Net profit (loss)
991,927 -967,853 -772,626 -167,292
Basic EPS
0 -0.01 -0.033 -0.01
Diluted EPS
0 -0.01 -0.033 -0.01
Basic Average Shares
184,943,349 99,609,650 23,291,434 23,752,506
Diluted Average Shares
184,943,349 99,609,650 23,291,434 23,752,506
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Derivative income(expense)$1,181,680 Total other income(expense), net$1,145,636 Interest expense$27,388 Interest expenseattributable to amortization...$8,656 Nonrelated Party$31,640 Related Party$27,425 Net profit (loss)before income taxes$991,927 Profit (loss) fromoperations-$153,709 Net revenue$59,065 Net profit (loss)$991,927 Total operatingexpenses$212,774 Consulting andprofessional fees$178,454 General andadministrative$32,104 Research and development$2,216

Regen BioPharma Inc (RGBPP)

Regen BioPharma Inc (RGBPP)